Cantel Medical has expanded its water purification and filtration unit.

To this end, the company has purchased the hemodialysis water business from Siemens' Water Technologies business unit.

In addition to expanding Mar Cor Purification's North American footprint, this acquisition is expected to be slightly accretive to Cantel Medical's earnings per share in fiscal year 2013 and beyond.

Mar Cor Purification is a subsidiary of Cantel Medical Corp., and is dedicated to providing innovative solutions through filtration, water purification, and disinfection technologies to the medical, life science and industrial marketplaces.       

The acquisition of the Siemens hemodialysis water customer base enables the company to realize increased efficiencies from Mar Cor Purification’s existing field service operations.

It also expands its footprint into new geographies.

“With this geographic expansion, Mar Cor will further improve its ability to service its large national customers. We look forward to continuing to provide our unique dialysis products and services to our new and existing customers,” said Curtis Weitnauer, president and CEO at Mar Cor Purification.

Cantel Medical sees this acquisition as a strategic move to strengthen its position as a major provider of water purification products and services for the dialysis industry.

“Our advanced heat-based disinfection water technology coupled with our nationwide service footprint makes Mar Cor the best choice for infection prevention and control to our dialysis customers,” said Cantel Medical's president and CEO, Andrew Krakauer. “We remain confident that our water purification and filtration segment will continue to demonstrate industry leading performance."

Cantel Medical provides infection prevention and control products in the healthcare market. The company was recently in the news when SmarTrend identified an uptrend for Cantel Medical in December 2012 at $27.71.